Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02948647 · ClinicalTrials.gov registry record · NA

Healthy Eating Through Reduction Of Excess Sugar

A NA study of NAFLD, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
113
Enrollment target
2
Study locations

NCT02948647: Completed NA study of NAFLD, sponsored by University of Southern California.

NCT02948647 is a NA study of NAFLD that has completed, run by University of Southern California. The registered enrollment target is 113 participants, below the 161-participant average among 26 other NAFLD trials with a reported enrollment target (30% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02948647, a NA study of NAFLD, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
113 participants
Enrollment target
2
Study locations

Study Summary

The purpose of the study is to determine the effect of dietary sugar reduction in obese children and examine whether there are differential effects based on genotype of a single amino acid substitution in the PNPLA3 gene that is highly prevalent in Hispanics and associated with significantly elevated liver fat.

Primary Outcome

Abdominal fat distribution (visceral fat versus subcutaneous abdominal fat), and liver fat fraction will be assessed by magnetic resonance imaging at the USC Radiology imaging center on a research-dedicated GE 3 Tesla scanner. Visceral adipose tissue, subcutaneous abdominal adipose tissue and fat in the entire liver will be determined using the 3D IDEAL method.

Conditions Studied

Interventions

  • OTHER Standard of care plus sugar-reduction education

Study Locations (2)

California

  • Children's Hospital Los Angeles - Los Angeles
  • Diabetes & Obesity Research Institute - Los Angeles

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2016-11
Est. Completion 2021-11
Phase NA
University of Southern California

617 total trials

What the finished NCT02948647 record still lists

NCT02948647 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 161-participant average among 26 other NAFLD trials with a reported enrollment target (30% lower).

The record links to 1 condition, with NAFLD appearing as the primary indexed condition, and to 1 intervention - of which Standard of care plus sugar-reduction education is the first listed.

NCT02948647 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02948647 about?

NCT02948647 is a clinical study titled "Healthy Eating Through Reduction Of Excess Sugar". The purpose of the study is to determine the effect of dietary sugar reduction in obese children and examine whether there are differential effects based on genotype of a single amino acid substitution in the PNPLA3 gene that is highly prevalent in Hispanics and associated with significantly elevate...

What is the current status of trial NCT02948647?

This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2016-11. Estimated completion is 2021-11.

What conditions does trial NCT02948647 study?

This clinical trial studies the following conditions: NAFLD.

What interventions are being tested in trial NCT02948647?

The interventions under investigation include: Standard of care plus sugar-reduction education (OTHER).

Who is sponsoring clinical trial NCT02948647?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02948647 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for NAFLD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02948647's enrollment target sits among peer trials

113 11th of 26 higher than 16 of 26 other NAFLD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NAFLD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00748254 · 113 participants

    Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

  • NCT04753190 · 113 participants · NA

    Light Timing Study

  • NCT05799248 · 113 participants · Phase 3

    Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

  • NCT07216105 · 113 participants · Phase 1

    FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02948647, the US trial registry maintained by the National Library of Medicine. NCT02948647 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.